#3 Clinical Trend: C Diff Treatment
Clostridium difficile, a potentially deadly disease, has a new enemy: itself! Researchers at the Loyola University Health System have used a “fight fire with fire” approach, giving patients spores of non-toxin-producing C difficile to create competition with the original, toxic strain. With phase III trials on the horizon, health care providers may have a new ally in the fight against the most common hospital-acquired infection.
For more in-depth clinical information, see Clostridium Difficile Colitis.
Medscape © 2015
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ryan Syrek. Top 10 Clinical Trends for May 2015 - Medscape - May 26, 2015.